Dr. Jorg Taubel and Dr. Ulrike Lorch will be attending the DDI Marbach Workshop, now in its 14th year. The Marbach Workshop continues to serve as a forum for in-depth discussions on crucial topics surrounding drug-drug interactions (DDIs).

As part of the Marbach Castle Drug-Drug Interaction Workshop Series, this event brings together stakeholders from various backgrounds, including the pharmaceutical industry, regulatory authorities, academia, and healthcare delivery.

The workshop series, a non-profit initiative, aims to facilitate the exchange of research-based knowledge on DDIs, encompassing not only drug-drug interactions but also food-drug and herb-drug interactions. By fostering communication and collaboration across disciplines and organisational boundaries, the workshop series seeks to advance scientific understanding and promote safer use of pharmaceutical products, particularly in geriatric and medically complex patient populations.

This year's workshop will be held at the Marbach Castle Conference Centre, nestled amidst the picturesque surroundings of the Western shore of Lake Constance, near the historic town of Stein am Rhein. It's an unparalleled opportunity to engage with leading experts, exchange insights, and contribute to the advancement of DDI research and clinical practice.

To find out more: https://www.ddi-workshop-marbach.org/ 

Latest news

Richmond Appoints Lisa Campbell as Director of Regulatory Strategy

April 23, 2025
Richmond Pharmacology is pleased to announce the appointment of Lisa Campbell as Director of Regulatory Strategy
Read more

Von Willebrand Disease Trial – First Stage of Hemab Therapeutics’ Trial Completed and New Patients Invited to Enrol

April 2, 2025
Richmond has completed dosing the first cohort of patients in Velora Pioneer, a phase 1/2 clinical trial investigating Hemab...
Read more

Events

Swiss Biotech Day 2025

5–6 May 2025
Richmond Pharmacology is pleased to confirm our participation at Swiss Biotech Day 2025
View event